ctDNA in HER2+ EBC Neoadjuvant Treatment
Clinical trial NCT07335081 · RECRUITING
Trial details
- NCT number
- NCT07335081
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2025-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.